CDMO Bora Pharmaceuticals Procures New Aseptic Filling And Closing System From AST

The globally recognized CDMO selects an isolated GENiSYS® C to be placed in its Baltimore, Maryland, aseptic fill-finish facility.

Tacoma WA — AST, a leading provider of flexible drug product manufacturing solutions, has announced the placement of its advanced isolated GENiSYS C fill-finish system with Bora Pharmaceuticals, a premier international contract development and manufacturing organization (CDMO). The flexible, multi-format system will be placed in their 87,000-square-foot clinical-to-commercial drug product manufacturing facility in Baltimore, Maryland.

“Bora is more frequently seeing demand for drug product fill and finish of potent drug candidates and approved treatments, as well as for rare and orphan diseases,” said J.D. Mowery, President of Bora’s CDMO Division. “The addition of a precision isolator line adds to our overall capacity and increases our flexibility and scalability. I look forward to adding to our capabilities in the U.S. so that we remain ready to meet rising demand from clients, both domestic and international.”

Bora’s addition of AST’s GENiSYS C line will leverage next-generation turnkey technology integrated with AST’s Atmos™ isolator that provides groundbreaking rapid low-concentration hydrogen peroxide technology from CURIS System. Featuring intuitive, recipe-driven changeover, the GENiSYS C minimizes operational downtime and streamlines processing for RTU vials, syringes, and cartridges on a single line. The fully integrated fill-finish solution is American-built with end-to-end supply, service, and project support from AST.

“AST’s isolated GENiSYS C is a flexible, high-performance solution designed for targeted, multi-modal production,” AST President and CEO Joe Hoff commented. “Bora’s extensive portfolio of services and solutions have enabled critical therapeutics to be delivered to patients in need worldwide. We’re thrilled to be partnering with Bora as they continue to add to their world-class fill-finish manufacturing services.”

About AST

AST is a pioneering force in aseptic fill-finish processing technology, committed to pushing the boundaries of industry standards. With a rich history of innovation, AST delivers cutting-edge solutions that enable pharmaceutical manufacturers to achieve optimal efficiency and product quality. To learn more about AST, visit www.ast-inc.com.

About Bora Pharmaceuticals

Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO) specializing in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, biologics, and sterile injectable pharmaceutical products. From our world-class sites in North America and Asia, we deliver drug products with unparalleled quality to more than 100 markets around the world. For more information, visit www.boracdmo.com.